Articles Related to Transforming growth factor
Increased High Mobility Group Protein A2/SMAD3 Relates to Ovarian Cancer Progression
The high mortality associated with ovarian cancer is generally related to the development of drug-resistant disease. HMGA2 protein, a member of the high-mobility group AT-hook (HMGA) family of non-histone chromatin binding factors, is overexpressed in high-grade serous ovarian and tubal carcinomas, though little is known about its contribution to disease progression and drug resistance. We sought to assess whether compositional changes in HMGA2 production were associated with ovarian cancer progression.
Editorial Board Members Related to Transforming growth factor
Tao Liu
Children's Cancer Institute
University of New South Wales
Australia
University of New South Wales
Australia
Jonathan R. Keller
Principal Investigator
Hematopoiesis and Stem Cell Biology Section
Center for Cancer Research
National Cancer Institute
United States
Hematopoiesis and Stem Cell Biology Section
Center for Cancer Research
National Cancer Institute
United States